betulinic acid has been researched along with Dyslipidemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Máñez, S; Ríos, JL | 1 |
| Klinnikova, MG; Koldysheva, EV; Lushnikova, EL; Mzhelskaya, MM; Sorokina, IV; Tolstikova, TG; Yuzhik, EI | 1 |
1 review(s) available for betulinic acid and Dyslipidemia
| Article | Year |
|---|---|
New Pharmacological Opportunities for Betulinic Acid.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Antineoplastic Agents; Antiviral Agents; Betulinic Acid; Cytotoxins; Diabetes Mellitus, Type 2; Dyslipidemias; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Inflammation; Metabolic Syndrome; Pentacyclic Triterpenes; Triterpenes | 2018 |
1 other study(ies) available for betulinic acid and Dyslipidemia
| Article | Year |
|---|---|
Cardiotoxic and Dyslipidemic Effects of Doxorubicin and Betulinic Acid Amide.
Topics: Amides; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Betulinic Acid; Body Weight; Cardiotoxicity; Catalase; Cell Size; Cholesterol, HDL; Cholesterol, LDL; Doxorubicin; Drug Combinations; Dyslipidemias; Male; Malondialdehyde; Myocardium; Myocytes, Cardiac; Organ Size; Pentacyclic Triterpenes; Rats; Rats, Wistar; Triglycerides; Triterpenes | 2016 |